|
|
||||||||
1 Department of Cell Pharmacology and 2 Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan
Hyperglycemia associated
with obstructive jaundice seriously affects the prognosis of
patients with hepatobiliary diseases. We investigated secretory
properties of isolated islets from bile duct-ligated (BDL) rats.
Pancreatic islets from BDL rats lost their secretory responses to
glucagon-like peptide-1 (GLP-1), although their responses to glucose
were normal. Loss of potentiation of insulin release was also observed
in glucagon and glucose-dependent insulinotropic peptide (GIP), whereas
modulation of the release by forskolin, dibutyryl cAMP, or epinephrine
remained unaffected. cAMP production by BDL islets was not increased by
these insulinotropic hormones. Serum levels of glucagon, but not GIP,
were increased in BDL rats. GLP-1 levels were also elevated, although
they did not reach statistical significance. Immunoblotting of trimeric G protein subunits demonstrated that Gs
L and
Gs
S, but not Gi
1/2 and
Gi
3/o
, were less expressed in BDL islets. Therefore,
unresponsiveness of the
-cell to cAMP-raising hormones is involved
in glucose intolerance under cholestasis. It results from diminished
expression of
-subunits of the relevant G protein, Gs,
and desensitization of receptors of these hormones.
cholestasis; pancreatic
-cell; glucagon-like peptide-1; trimeric
G protein; adenosine 3',5'-cyclic monophosphate
This article has been cited by other articles:
![]() |
M Marzioni, G Alpini, S Saccomanno, C Candelaresi, J Venter, C Rychlicki, G Fava, H Francis, L Trozzi, and A Benedetti Exendin-4, a glucagon-like peptide 1 receptor agonist, protects cholangiocytes from apoptosis Gut, July 1, 2009; 58(7): 990 - 997. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |